Copyright © Philip M. Parker, INSEAD. Terms of Use.
| ANTIBACTERIAL SUBSTANCE
ANTIBACTERIAL SUBSTANCE BE-24566B
ANTIBACTERIAL SUBSTITUTED 7-ACYLAMINO-3-(METHYLHYDRAZONO) METHYL-CEPHALOSPORINS AND INTERMEDIATES
ANTIBACTERIAL SUSCEPTIBILITY TEST
ANTIBACTERIAL SWABS
ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM
ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM TOGETHER WITH AN ANTIBIOTIC
ANTIBACTERIAL TITANIA AND PROCESS FOR PRODUCING THE SAME
ANTIBACTERIAL VASCULAR PROSTHESIS AND SURGICAL SUTURE
ANTIBACTERIAL WATER ABSORBING COMPOSITION AND METHOD OF MANUFACTURE
ANTIBACTERIAL ZEOLITE CAUSING LITTLE DISCOLORATION AND METHOD OF THE PRODUCTION THEREOF
ANTIBACTERIAL, ANTI-NEMATODE AND/OR PLANT-CELL ACTIVATING COMPOSITION, AND CHITINOLYTIC MICROORGANISMS FOR PRODUCING THE SAME
ANTIBACTERIAL, ANTIFUNGAL ALUMINUM BUILDING MATERIALS AND FIXTURES USING THE MATERIALS
ANTIBACTERIAL, ANTIFUNGAL AND ANTIVIRAL AGENT
ANTIBACTERIAL, ANTIFUNGAL OR ANTIALGAL ARTICLE AND PROCESS FOR PRODUCING SAME
ANTIBACTERIAL, ANTIFUNGAL SILICONE RUBBER COMPOSITION
ANTIBACTERIAL, BACTERICIDAL AND ANTISEPTIC AGENT, DERMATOLOGIC PREPARATION AND DETERGENT COMPOSITION
ANTIBACTERIAL, MILDEW RESISTANT ORGANOPOLYSILOXANE COMPOSITIONS
ANTIBACTERIAL/ANTIVIRAL FILTERING DEVICE FOR VENTILATION SYSTEMS
ANTIBACTERIAL-WOUND HEALING COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME
ANTIBACTERIALLY ACTIVE EXTRACTS FROM THE MARINE ALGAE CHAETOCEROS AND METHODS OF USE
ANTIBALLISTIC PROTECTIVE HELMET
ANTIBALLISTIC SHAPED PART
ANTIBIOFOULING METHOD AND APPARATUS FOR OPTICAL SENSORS
ANTIBIOTIC 10381A, AND PROCESS FOR THE PREPARATION OF ANITBIOTICS 10381B
ANTIBIOTIC 10381A.SUB.1 AND PROCESS FOR THE PREPARATION OF ANTIBIOTICS 10381B
ANTIBIOTIC 31F508 ALPHA1, ALPHA2, BETA1 AND BETA2
ANTIBIOTIC 31F508.ALPHA..SUB.1, 31F508.ALPHA..SUB.2, 31F508.BETA..SUB.1, 31F508.BETA..SUB.2
ANTIBIOTIC 42D005 .ALPHA. AND .BETA.
ANTIBIOTIC 5-LIPOXYGENASE INHIBITORS
ANTIBIOTIC A 40926 ESTER DERIVATIVES
ANTIBIOTIC A/16686 RECOVERY PROCESS
ANTIBIOTIC A10255 COMPLEX AND FACTORS, AND PROCESS AND PRODUCTION THEREFOR
ANTIBIOTIC A82810
ANTIBIOTIC AB-041 DERIVED FROM STREPTOMYCES SP. NCIMB 40428, HERBICIDAL COMPOSITIONS, AND METHODS OF USE
ANTIBIOTIC AGENT
ANTIBIOTIC AGENTS
ANTIBIOTIC ALISAMYCIN AND ITS USE
ANTIBIOTIC AND CYTOTOXIC DRUG SUSCEPTIBILITY ASSAYS USING RESAZURIN AND POISING AGENTS
ANTIBIOTIC BIOMASS ANIMAL FEED COMPOSITIONS
ANTIBIOTIC BRAVOMICINS
ANTIBIOTIC C-3 CATECHOL-SUBSTITUTED CEPHALOSPORIN COMPOUNDS, COMPOSITIONS AND METHOD OF USE THEREOF
ANTIBIOTIC C-3 CYCLOBUTENEDIONE SUBSTITUTED (1-CARBA) CEPHALOSPORIN COMPOUNDS, CMPOSITIONS, AND METHODS OF USE THEREOF
ANTIBIOTIC C-3 CYCLOBUTENEDIONE SUBSTITUTED (1-CARBA)CEPHALOSPORIN COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF
ANTIBIOTIC C-3 DI-HYDROXYPHENYL SUBSTITUTED CEPHALOSPORIN COMPOUNDS, COMPOSITIONS AND METHOD OF USE THEREOF
ANTIBIOTIC C-3 DITHIOACETAL-SUBSTITUTED CARBAPENEM COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF
ANTIBIOTIC C-7 CATECHOL-SUBSTITUTED CEPHALOSPORIN COMPOUNDS, COMPOSITIONS, AND METHOD OF USE THEREOF
ANTIBIOTIC CALCIUM PHOSPHATE COATING
ANTIBIOTIC CAPRAZAMYCINS AND PROCESS FOR PRODUCING THE SAME
ANTIBIOTIC CARBAPENEM COMPOUNDS
ANTIBIOTIC COCKTAIL AND METHOD OF USE
ANTIBIOTIC COMBINATION
ANTIBIOTIC COMPOSITION
ANTIBIOTIC COMPOSITION FOR INHIBITION OF ANGIOGENESIS
ANTIBIOTIC COMPOSITION FROM ALCALIGENES SPECIES AND METHOD FOR MAKING AND USING THE SAME
ANTIBIOTIC COMPOSITION WITH INHIBITOR
ANTIBIOTIC COMPOSITIONS AND METHOD FOR USING SAME
ANTIBIOTIC COMPOSITIONS AND METHODS FOR USING SAME
ANTIBIOTIC COMPOUND
ANTIBIOTIC COMPOUNDS
ANTIBIOTIC COMPOUNDS AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS
ANTIBIOTIC COMPOUNDS AND THEIR PRODUCTION
ANTIBIOTIC CRYPTDIN PEPTIDES AND METHODS OF THEIR USE
ANTIBIOTIC CYCLOPEPTIDE FERMENTATION PRODUCT
ANTIBIOTIC CYTOSPORACIN
ANTIBIOTIC EICOSENOIC ACIDS
ANTIBIOTIC ELUDING INTRAMEDULLARY NAIL APPARATUS
ANTIBIOTIC FOR METHICILLIN RESISTANT BACTERIA
ANTIBIOTIC FORMULATION AND A METHOD OF MAKING THIS FORMULATION
ANTIBIOTIC FORMULATION AND USE FOR BACTERIAL INFECTIONS
ANTIBIOTIC FORMULATION AND USE FOR DRUG RESISTANT INFECTIONS
ANTIBIOTIC GE 2270
ANTIBIOTIC GE 2270 FACTORS A.SUB.1, A.SUB.2, A.SUB.3 AND H
ANTIBIOTIC GE 2270 FACTORS B.SUB.1, B.SUB.2, C.SUB.1, C.SUB.2, D.SUB.1, D.SUB.2, E AND T
ANTIBIOTIC GE 2270 FACTORS C.SUB.2A
ANTIBIOTIC GE1655 COMPLEX AND ITS FACTORS A, B, AND C
ANTIBIOTIC HIGH-PRESSURE LAMINATES
ANTIBIOTIC HYDROPHILIC POLYMER COATING
ANTIBIOTIC IMPREGNATED MYRINGOTOMY VENTILATION TUBE
ANTIBIOTIC INDUCIBLE/REPRESSIBLE GENETIC CONSTRUCT FOR GENE THERAPY OR GENE IMMUNIZATION
ANTIBIOTIC LL-14E605.BETA. AND O-METHYL-LL-14E605.BETA.
ANTIBIOTIC LL-D37187.ALPHA.
ANTIBIOTIC LL-E19020 ALPHA.SUB.1
ANTIBIOTIC LL-E19020 GAMMA
ANTIBIOTIC LL-E19085
ANTIBIOTIC MACROLIDES
ANTIBIOTIC MICROWAVE OVEN
ANTIBIOTIC N-ACETYLBENANOMICIN B, AND THE PRODUCTION AND USES THEREOF
ANTIBIOTIC OIL SUSPENSIONS
ANTIBIOTIC OXAZOLIDINONE DERIVATIVES
ANTIBIOTIC PENEM COMPOUNDS
ANTIBIOTIC PEPTIDES
ANTIBIOTIC PEPTIDES BEARING AMINOALKYLTHIOETHER MOIETIES
ANTIBIOTIC PEPTIDES CONTAINING D-AMINO ACIDS
ANTIBIOTIC PEPTIDES FROM BOVINE MILK
ANTIBIOTIC PREPARATION AND USE OF THE SAME IN PLANTS
ANTIBIOTIC PRODRUGS
ANTIBIOTIC PRODUCED BY BACILLUS SUBTILIS ATCC 55422 CAPABLE OF INHIBITING BACTERIA
ANTIBIOTIC PRODUCED BY PSEUDOMONAS SP. AND PROCESS FOR THE PREPARATION THEREOF
ANTIBIOTIC PRODUCING MICROBE
ANTIBIOTIC PRODUCING MICROORGANISM
ANTIBIOTIC PRODUCT, USE AND FORMULATION THEREOF
ANTIBIOTIC PURIFICATION METHOD
ANTIBIOTIC PYRIDINE COMPOUND
ANTIBIOTIC QUINOLONES AND DERIVATIVES
ANTIBIOTIC RESISTANT STRAIN OF LACTOBACILLUS ACIDOPHILUS
ANTIBIOTIC REUTERIN
ANTIBIOTIC STALOBACINS
ANTIBIOTIC SUSCEPTIBILITY TEST
ANTIBIOTIC SYNTHESIS
ANTIBIOTIC TKR2648 AND PROCESS FOR PRODUCING THE SAME
ANTIBIOTIC TKR2999, PROCESS FOR THE PREPARATION THEREOF AND MICROBE
ANTIBIOTIC TKR459, PRODUCTION METHOD, AND MICROORGANISM
ANTIBIOTIC TOOTHPASTE
ANTIBIOTIC TREATMENT OF AGE-RELATED MACULAR DEGENERATION
ANTIBIOTIC TRIENOMYCINS AND THEIR PRODUCTION
ANTIBIOTIC WAP-8294A, METHOD FOR PREPARING THE SAME AND ANTIBACTERIAL COMPOSITION
ANTIBIOTIC ZEOLITE-CONTAINING FILM
ANTIBIOTIC, ARANOROSIN, A MICROBIOLOGICAL PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF AS A PHARMACEUTICAL
ANTIBIOTIC, BALHIMYCIN, A PROCESS FOR ITS PRODUCTION AND ITS USE AS PHARMACEUTICAL
ANTIBIOTIC, CAMMUNOCIN, A PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF AS A PHARMACEUTICAL
ANTIBIOTIC, DEOXYMULUNDOCANDIN, A PROCESS FOR ITS PRODUCTION AND ITS USE AS MEDICAMENT
ANTIBIOTIC, FEGLYMYCIN, PROCESSES FOR ITS PREPARATION AND ITS USE
ANTIBIOTIC, MERSACIDIN, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS A PHARMACEUTICAL
ANTIBIOTIC/BENZOYL PEROXIDE DISPENSER
ANTIBIOTIC/MEDICATED GUTTA PERCHA POINT
ANTIBIOTIC-BASED GENE REGULATION SYSTEM
ANTIBIOTIC-PRODUCING STRAIN OF BACILLUS AND METHODS FOR CONTROLLING PLANT DISEASES
ANTIBIOTICS
ANTIBIOTICS 10381V, W, X,Y, Z1, Z2, PRE-B AND T
ANTIBIOTICS AA-896
ANTIBIOTICS AB-023 AND PROCESS FOR PREPARING THEM
ANTIBIOTICS AND METHODS OF USING THE SAME
ANTIBIOTICS AND PROCESS FOR PREPARATION
ANTIBIOTICS FOR BIOLOGICAL CONTROL OF POST HARVEST DISEASES
ANTIBIOTICS FROM MICROBISPORA
ANTIBIOTICS GE 23077, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS, AND USE THEREOF
ANTIBIOTICS GE 37468 A, B AND C
ANTIBIOTICS HAVING IMMUNOSUPPRESSIVE ACTIVITY, DELAMINOMYCINS AND PROCESSES FOR THE PRODUCTION OF THE SAME
ANTIBIOTICS LL-E19020 EPSILON AND LL-E19020 EPSILON.SUB.1
ANTIBIOTICS MER-AF1032A AND MER-AF1032B
ANTIBIOTICS NK374186A, NK374186B, NK374186B3 AND NK374186C3, PROCESS FOR PRODUCING THE SAME, AND USE OF THE SAME
ANTIBIOTICS PLUSBACIN
ANTIBIOTICS RK-1061 AND PROCESS FOR PREPARING THE SAME
ANTIBIOTICS TKR1912-I AND TKR1912-II AND PROCESS FOR PRODUCING THE SAME
ANTIBIOTICS UNPHENELFAMYCIN AND PHENELFAMYCINS A-D
ANTIBIOTICS, DEXYLOSYLBENANOMICIN B
ANTIBLOCK AGENT FOR POLYOLEFIN FILMS
ANTIBLOCK COATING FOR HOT MELT ADHESIVES
ANTIBLOCK SYSTEM
ANTIBLOOMING STRUCTURE FOR SOLID-STATE IMAGE SENSOR
ANTIBLOW-BY PISTON AND SEAL CONSTRUCTION FOR HIGH TEMPERATURE APPLICATIONS
ANTIBODIES AGAINST A HOST CELL ANTIGEN COMPLEX FOR PRE AND POST EXPOSURE PROTECTION FROM INFECTION BY HIV
ANTIBODIES AGAINST A HOST CELL ANTIGEN COMPLEX FOR PRE- AND POST-EXPOSURE PROTECTION FROM INFECTION BY HIV
ANTIBODIES AGAINST A SECRETED POLYPEPTIDE THAT STIMULATES RELEASE OF PROTEOGLYCANS FROM CARTILAGE
ANTIBODIES AGAINST ANALOGS OF BRAIN-DERIVED NEUROTROPHIC FACTOR
ANTIBODIES AGAINST E-SELECTIN
ANTIBODIES AGAINST FIBRIN: IMMUNOGEN TO BE USED FOR THE PREPARATION OF THE ANTIBODIES, PROCEDURE FOR DETERMINING FIBRIN WITH THE ANTIBODIES AND PHARMACEUTICAL PREPARATION BASED ON THE ANTIBODIES
ANTIBODIES AGAINST FIBRIN; IMMUNOGENIC PEPTIDES SUITABLE FOR PREPARING THE ANTIBODIES, METHOD FOR DETERMINING FIBRIN AND PHARMACEUTICAL PREPARATION BASED ON THE ANTIBODIES
ANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR 11
ANTIBODIES AGAINST FLT3 LIGAND
ANTIBODIES AGAINST HEART MUSCLE ACTIN
ANTIBODIES AGAINST HEPATITIS G VIRUS AND THEIR USE FOR THE DIAGNOSTIC DETECTION OF HGV AND AS A THERAPEUTIC AGENT
ANTIBODIES AGAINST HIGHLY CONSERVED AMINO ACID SEQUENCES OF INSULIN A PROCESS FOR THE PREPARATION OF THESE ANTIBODIES AND THE USE THEREOF IN IMMUNOASSAYS
ANTIBODIES AGAINST HUMAN CD40
ANTIBODIES AGAINST HUMAN HERPESVIRUS-6(HHV-6) AND METHOD OF USE
ANTIBODIES AGAINST HUMAN IL-12
ANTIBODIES AGAINST LIGAND FOR RECEPTOR ACTIVATOR OF NF-KB
ANTIBODIES AGAINST LYMPHOCYTE-ASSOCIATED CELL SURFACE PROTEIN LAM-1
ANTIBODIES AGAINST PHOSHORYLATED VASP (VASODILATOR-STIMULATED PHOSPHOPROTEIN), HYBRIDOMA CELLS FOR THEIR PREPARATION, AND THEIR USE
ANTIBODIES AGAINST SEMP1(P23)
ANTIBODIES AGAINST STREPTOCOCCUS
ANTIBODIES AGAINST SULFOTRANSFERASE
ANTIBODIES AGAINST T CELLS AS THERAPEUTICS
ANTIBODIES AGAINST THE INTERFERON (IFN) .ALPHA./.BETA. RECEPTOR (IFNAR2) THAT PREFERENTIALLY BLOCK THE ACTIVITY OF IFN-.ALPHA.
ANTIBODIES AGAINST THE RECEPTOR PROTEIN FOR HUMAN B CELL STIMULATORY FACTOR-2
ANTIBODIES AGAINST THE TUMOR SUPPRESSOR GENE ING1
ANTIBODIES AGAINST TYPE A BOTULINUM NEUROTOXIN
ANTIBODIES AGAINST TYROSINE KINASE RECEPTOR FLK-1
ANTIBODIES AND ASSAY FOR DETECTING MUTANT APC PROTEINS
ANTIBODIES AND DIAGNOSTIC METHODS FOR THE DIAGNOSIS OF PESTIVIRUSES
ANTIBODIES AND FRAGMENTS THEREOF WHICH BIND THE CARBOXYL-TERMINUS OF AN AMINO-TERMINAL FRAGMENT OF .BETA.APP
ANTIBODIES AND IMMUNOASSAYS FOR DETECTING PLATELET TRANSFUSION REFRACTORINESS
ANTIBODIES AND METHODS OF MAKING ANTIBODIES TO HUMAN THYROID PROTEIN ZSIG45
ANTIBODIES AND OTHER BINDING MOLECULES SPECIFIC FOR HEPATITIS B VIRAL ANTIGENS
ANTIBODIES AND PROTEINS USEFUL FOR ASSAYING VIRUS INFECTION IN GRAPE PLANTS
ANTIBODIES AND THEIR USE
ANTIBODIES BINDING PORTIONS, AND PROBES RECOGNIZING AN ANTIGEN OF PROSTATE EPITHELIAL CELLS BUT NOT ANTIGENS CIRCULATING IN THE BLOOD
ANTIBODIES CATALYZING DEAMIDATION OF PROTEINS
ANTIBODIES DIRECTED AGAINST BINDING ASSOCIATED EPITOPES
ANTIBODIES DIRECTED AGAINST BINDING-ASSOCIATED EPITOPES
ANTIBODIES DIRECTED AGAINST CD30 LIGAND
ANTIBODIES DIRECTED AGAINST CELLULAR CORECEPTORS FOR HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USING THE SAME
ANTIBODIES DIRECTED AGAINST ELK LIGAND
ANTIBODIES DIRECTED AGAINST PEPTIDES DERIVED FROM THE SMR1 POLYPEPTIDE
ANTIBODIES DIRECTED AGAINST THE ALPHA INTERFERON RECEPTOR
ANTIBODIES DIRECTED AGAINST TRAIL
ANTIBODIES DIRECTED TO PAGC PEPTIDES FOR THE DETECTION OF SALMONELLAE
ANTIBODIES DIRECTED TO THE BINDING PROTEINS OF BACILLUS THURINGIENSIS AND THEIR USE
ANTIBODIES DIRECTED TOWARD EXTRACELLULAR SIGNAL-RELATED KINASES
ANTIBODIES DRAWN TO THE EPS15 SUBSTRATE FOR EPIDERMAL GROWTH FACTOR RECEPTOR KINASE
ANTIBODIES FOR AND TREATMENT TO PREVENT OR REDUCE THE SEVERITY OF XENOGRAFT REJECTION
ANTIBODIES FOR DETECTING P27 PROTEIN
ANTIBODIES FOR DETECTION OF HUMAN MDM2 PROTEIN
ANTIBODIES FOR DETECTION OF WATER TREATMENT POLYMERS
ANTIBODIES FOR GM-CSF RECEPTOR AND USES THEREOF
ANTIBODIES FOR HUMAN PHOSPHOLIPASE INHIBITORY PROTEIN (HPIP)
ANTIBODIES FOR INHIBITING BLOOD COAGULATION AND METHODS OF USE THEREOF
ANTIBODIES FOR JUDGING POSSIBILITY OF THE ONSET OF BOVINE LEUKEMIA
ANTIBODIES FOR MEVALONIC ACID AND METHODS FOR IMMUNOLOGICAL DETERMINATION OF MEVALONIC ACID BY USING THEM
ANTIBODIES FOR MODULATING HETEROTYPIC E-CADHERIN INTERACTIONS WITH HUMAN T LYMPHOCYTES
ANTIBODIES FOR NF-AT INTERACTING PROTEIN, NIP45
ANTIBODIES FOR P-GLYCOPROTEIN ENCODED BY THE MDR1 GENE AND USES THEREOF
ANTIBODIES FOR PHB
ANTIBODIES FOR PROVIDING PROTECTION AGAINST P. VIVAX MALARIA INFECTION
ANTIBODIES FOR RECOGNITION OF ALK PROTEIN TYROSINE/KINASE RECEPTOR
ANTIBODIES FOR SALICYLATE AND THEIR PREPARATION
ANTIBODIES FOR THE ALPHA PLATELET-DERIVED GROWTH FACTOR RECEPTOR
ANTIBODIES FOR THE DETECTION OF BEER SPOILAGE LACTIC ACID BACTERIA AND KIT EMPLOYING THE ANTIBODIES
ANTIBODIES FOR THE DETECTION OF PRION PROTEIN AS AN INDICATION OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
ANTIBODIES FOR THE SELECTIVE IMMUNOLOGICAL DETERMINATION OF BILE ACIDS IN BIOLOGICAL MATRICES
ANTIBODIES FOR USE IN ANTILYMPHOCYTE ANTIBODY THERAPY
ANTIBODIES HAVING BINDING SPECIFICITY TO SHET2, AN ENTEROTOXIN OF SHIGELLA FLEXNERI 2A
ANTIBODIES HAVING MODIFIED CARBOHYDRATE CONTENT AND METHODS OF PREPARATION AND USE
ANTIBODIES HAVING SPECIFIC REACTIVITY FOR A MATRIX-ASSOCIATING DNA-BINDING PROTEIN
ANTIBODIES IMMUNOLOGICALLY REACTIVE WITH BROAD-SPECTRUM .DELTA. ENDOTOXINS
ANTIBODIES IMMUNOLOGICALLY SPECIFIC FOR A SIGNAL MEDIATOR PROTEIN THAT INDUCES CELLULAR MORPHOLOGICAL ALTERATIONS
ANTIBODIES IMMUNOREACTIVE WITH LEUKEMIA INHIBITORY FACTOR RECEPTORS
ANTIBODIES IMMUNOREACTIVE WITH THE T-CELL GROWTH FACTOR, P40
ANTIBODIES MODIFIED WITH TOXIC SUBSTANCE
ANTIBODIES OF ISOLATED DOMAINS OF TYPE IV COLLAGEN MODIFY CELL INTERACTIONS
ANTIBODIES OR ANTIGENS BOUND TO A MACROPOROUS HYDROPHOBIC SYNTHETIC POLYMER CLOTH FOR IMMUNOLOGICAL TECHNIQUES
ANTIBODIES PRODUCED AGAINST CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG BINDING PROTEINS
ANTIBODIES PRODUCED FROM LIPOPOLYSACCHARIDE-STIMULATED MONOCYTE/MACPROPHAGE CELL LINES
ANTIBODIES RAISED AGAINST IMMUNOGENIC CONJUGATES OF GRAM-NEGATIVE BACTERIAL AUTOINDUCER MOLECULES
ANTIBODIES RAISED AGAINST PROTEINS OF LEISHMANIA WHICH ARE EXPRESSED AT AN INCREASED LEVEL IN THE AMASTIGOTE FORM
ANTIBODIES REACTIVE WITH BIOLOGICAL MARKERS OF BENIGN PROSTATE HYPERPLASIA
ANTIBODIES REACTIVE WITH HUMAN CARCINOMAS
ANTIBODIES REACTIVE WITH NORMAL AND ONCOGENIC FORMS OF THE RAS P21 PROTEIN
ANTIBODIES REACTIVE WITH RETINOBLASTOMA BINDING PROTEINS AND METHODS OF USING SAME
ANTIBODIES REACTIVE WITH VEGF-C, A LIGAND FOR THE FLT4 RECEPTOR TYROSINE KINASE (VEGFR-3)
ANTIBODIES RECOGNIZING TIE RECEPTOR TYROSINE KINASE AND USES THEREOF
ANTIBODIES RECOGNIZING TUMOR ASSOCIATED ANTIGEN CA 55.1
ANTIBODIES SPECIFIC FOR .BETA.6 INTEGRINS
ANTIBODIES SPECIFIC FOR A HAEMOSTATIC PROTEIN THEIR USE FOR ISOLATING PROTEIN, HAEMOSTATIC COMPOSITIONS DEVOID OF PROTEOLYTIC CLEAVAGE PRODUCTS OF THE PROTEIN
ANTIBODIES SPECIFIC FOR BCL-2 GENE PRODUCT
ANTIBODIES SPECIFIC FOR CD4-BINDING DOMAIN OF HIV-1
ANTIBODIES SPECIFIC FOR CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR AND USES THEREFOR
ANTIBODIES SPECIFIC FOR D-MYO-INOSITOL 1, 4, 5-TRISPHOSPHATE AND THE ENZYME-LINKED IMMUNOSORBENT ASSAY OF D-MYO-INOSITOL 1, 4, 5-TRISPHOSPHATE | ANTIBODIES SPECIFIC FOR D-MYO-INOSITOL 1,4,5-TRISPHOSPHATE AND THE ENZYME-LINKED IMMUNOSORBENT ASSAY OF D-MYO-INOSITOL 1,4,5-TRISPHOSPHATE
ANTIBODIES SPECIFIC FOR E-SELECTIN AND THE USES THEREOF
ANTIBODIES SPECIFIC FOR EGF MOTIF PROTEINS
ANTIBODIES SPECIFIC FOR EITHER RAS PHOTO-ONCOGENE ENCODED P21 PROTEINS OR RAS ONCOGENE ENCODED P21 PROTEINS BUT NOT FOR BOTH AND METHOD OF PRODUCING SAME
ANTIBODIES SPECIFIC FOR ELAM-1 AND THE USE THEREOF
ANTIBODIES SPECIFIC FOR FKHSF GENE PRODUCTS
ANTIBODIES SPECIFIC FOR FRAGILE X RELATED PROTEINS AND METHOD OF USING THE SAME
ANTIBODIES SPECIFIC FOR FULLERENES
ANTIBODIES SPECIFIC FOR GROWTH DIFFERENTIATION FACTOR-7
ANTIBODIES SPECIFIC FOR GROWTH DIFFERENTIATION FACTOR-8 AND METHODS OF USING SAME
ANTIBODIES SPECIFIC FOR HEREGULIN 2-.ALPHA.
ANTIBODIES SPECIFIC FOR HLH .BETA. CORE FRAGMENT
ANTIBODIES SPECIFIC FOR HT.SUB.M4
ANTIBODIES SPECIFIC FOR HU-B1.219, A NOVEL HEMATOPOIETIN RECEPTOR
ANTIBODIES SPECIFIC FOR HUMAN ADSEVERIN
ANTIBODIES SPECIFIC FOR HUMAN CRIPTO-RELATED POLYPEPTIDE CR-3
ANTIBODIES SPECIFIC FOR HUMAN INOSITOL MONOPHOSPHATASE H1
ANTIBODIES SPECIFIC FOR HUMAN PANCREATITIS ASSOCIATED PROTEIN
ANTIBODIES SPECIFIC FOR HUMAN PROSTATE GLANDULAR KALLKREIN
ANTIBODIES SPECIFIC FOR HUMAN STROMELYSIN-3 AND A METHOD FOR DETECTION OF STROMELYSIN-3
ANTIBODIES SPECIFIC FOR HUMAN THYMOSIN .BETA.15 PROTEIN AND USES THEREOF
ANTIBODIES SPECIFIC FOR ISOTYPE SPECIFIC DOMAINS OF HUMAN IGM AND HUMAN IGG EXPRESSED OR THE B CELL SURFACE
ANTIBODIES SPECIFIC FOR LIPOPOLYSACCHARIDE BINDING PROTEIN
ANTIBODIES SPECIFIC FOR MEGAKARYOCYTE DIFFERENTIATION FACTOR
ANTIBODIES SPECIFIC FOR MTS2 POLYPEPTIDE
ANTIBODIES SPECIFIC FOR NATIVE PRP.SUP.SC
ANTIBODIES SPECIFIC FOR NATIVE PRPSC
ANTIBODIES SPECIFIC FOR NEUTROPHIC CHEMOTACTIC FACTOR
ANTIBODIES SPECIFIC FOR ONCOFETAL FIBRONECTIN
ANTIBODIES SPECIFIC FOR OVCA DNA ENCODED PROTEINS AND METHODS FOR THEIR USE
ANTIBODIES SPECIFIC FOR PEPTIDE CORRESPONDING TO CD44 EXON 6, AND USE OF THESE ANTIBODIES FOR DIAGNOSIS OF TUMORS
ANTIBODIES SPECIFIC FOR PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE
ANTIBODIES SPECIFIC FOR PROTEINS HAVING POLYGLUTAMINE EXPANSIONS
ANTIBODIES SPECIFIC FOR RETINOIC ACID RECEPTOR-.GAMMA.
ANTIBODIES SPECIFIC FOR RSE RECEPTOR PROTEIN TYROSINE KINASE
ANTIBODIES SPECIFIC FOR SEMAPHORIN-LIKE POLYPEPTIDES
ANTIBODIES SPECIFIC FOR SEROREACTIVE REGIONS ON HPV 16 PROTEIN E1
ANTIBODIES SPECIFIC FOR SOLUBLE TRUNCATED INTEGRINS
ANTIBODIES SPECIFIC FOR STAPHYLOCOCCUS AUREUS, AND USE THEREOF
ANTIBODIES SPECIFIC FOR STREPTOCOCCUS PNEUMONIAE HEMIN/HEMOGLOBIN-BINDING ANTIGENS
ANTIBODIES SPECIFIC FOR THE DF3 CARCINOMA ASSOCIATED ANTIGEN
ANTIBODIES SPECIFIC FOR THE EXTRACELLULAR DOMAIN OF NYK/FLK-1 PROTEIN AND USES THEREOF
ANTIBODIES SPECIFIC FOR THE GROUP ANTIGEN OF ASTROVIRUSES
ANTIBODIES SPECIFIC FOR TRP-2 A HUMAN TUMOR ANTIGEN RECOGNIZED BY CYTOTOXIC T LYMPHOCYTES
ANTIBODIES SPECIFIC FOR TYPE II MUTANT EGTR
ANTIBODIES SPECIFIC FOR UNGULATE PRP
ANTIBODIES SPECIFIC FOR VASCULAR ENDOTHELIAL GROWTH FACTOR-B
ANTIBODIES SPECIFIC TO QUINOLINIC ACID
ANTIBODIES SPECIFIC TOWARDS GP 48
ANTIBODIES SPECIFIC TOWARDS HIV-1 GP 48
ANTIBODIES SPECIFICALLY IMMUNOREACTIVE WITH HUMAN BRAIN CA.SUP.2+ /CALMODULIN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE
ANTIBODIES SPECIFICALLY REACTIVE WITH INTEGRIN .BETA.6 SUBUNITS
ANTIBODIES SPECIFICALLY REACTIVE WITH T-CADHERIN
ANTIBODIES SPECIFICALLY REACTIVE WITH THROMBIN RECEPTOR AND ITS COMPONENTS
ANTIBODIES SPECIFICALLY RECOGNIZING SOMATOTROPIN BINDING PROTEINS
ANTIBODIES THAT ARE IMMUNOREACTIVE WITH INTERLEUKIN-4 RECEPTORS
ANTIBODIES THAT ARE IMMUNOREACTIVE WITH INTERLEUKIN-7
ANTIBODIES THAT BIND AN ADIPOCYTE-SPECIFIC PROTEIN HOMOLOG
ANTIBODIES THAT BIND CHEMOKINE TECK
ANTIBODIES THAT BIND DEOXYRIBONUCLEASE II.BETA. ENZYME PROTEINS
ANTIBODIES THAT BIND EPSTEIN BARR VIRUS INDUCED PROTEINS
ANTIBODIES THAT BIND HEK LIGANDS
ANTIBODIES THAT BIND HUMAN HAEMOPOIETIC MATURATION FACTOR
ANTIBODIES THAT BIND IMMUNOMODULATORS
ANTIBODIES THAT BIND NOVEL CARBOHYDRATE LIGANDS (MYELOROLLINS) THAT CAUSE E-SELECTIN DEPENDENT CELL ROLLING, AND USES THEREOF
ANTIBODIES THAT BIND PEPTIDES FROM THE HPTH SEQUENCE (1-37)
ANTIBODIES THAT BIND TESTIS-SPECIFIC INSULIN HOMOLOG POLYPEPTIDES
ANTIBODIES THAT BIND THE CYTOKINE DESIGNATED LERK-5
ANTIBODIES THAT BIND TO .ALPHA.2-ANTIPLASMIN CROSSLINKED TO FIBRIN WHICH DO NOT INHIBIT PLASMA .ALPHA.2-ANTIPLASMIN
ANTIBODIES THAT BIND TO A LIGAND-INDUCED BINDING SITE ON GPIIIA
ANTIBODIES THAT BIND TO A LIGAND-INDUCED BINDING SITE ON INTEGRIN AND INDUCE INTEGRIN ACTIVATION
ANTIBODIES THAT BIND TO ENDOGLIN
ANTIBODIES THAT BIND TUMOR NECROSIS FACTOR DELTA
ANTIBODIES THAT BINDS GROWTH DIFFERENTIATION FACTOR 5
ANTIBODIES THAT DEFINE UNIQUE MENINGOCOCCAL B EPITOPES AND VACCINE COMPOSITIONS
ANTIBODIES THAT MIMIC ACTIONS OF NEUROTROPHINS
ANTIBODIES THAT REACT WITH VARIANT CD44 SURFACE PROTEINS
ANTIBODIES THAT SELECTIVELY BIND QUADRUPLEX NUCLEIC ACIDS
ANTIBODIES THAT SPECIFICALLY BIND A BACILLUS THURINGIENSIS TOXIN RECEPTOR
ANTIBODIES THAT SPECIFICALLY BIND ACT-4-L-H-1 LIGAND
ANTIBODIES THAT SPECIFICALLY BIND CYTOSTATIN III
ANTIBODIES THAT SPECIFICALLY BIND DNAX LEUKOCYTE ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR
ANTIBODIES THAT SPECIFICALLY BIND TO ALK-7, A NOVEL SERINE THREONINE KINASE RECEPTOR
ANTIBODIES THAT SPECIFICALLY BIND TO AND INHIBIT HUMAN SYNOVIAL PHOSPHOLIPASE A.SUB.2 TYPE A
ANTIBODIES THAT SPECIFICALLY REACT WITH SEROREACTIVE REGIONS ON HPV 16 PROTEINS E1 AND E2
ANTIBODIES TO .ALPHA.V.BETA.3 INTEGRIN
ANTIBODIES TO .BETA.-AMYLOIDS OR THEIR DERIVATIVES AND USE THEREOF
ANTIBODIES TO A CHEMOKINE EXPRESSED IN INFLAMED ADENOID
ANTIBODIES TO A G PROTEIN-ACTIVATED, INWARD RECTIFYING KGA POTASSIUM CHANNEL
ANTIBODIES TO A HUMAN INTEGRIN ALPHA/BETA HETERODIMERIC PROTEIN
ANTIBODIES TO A HUMAN PF4 SUPERFAMILY RECEPTOR
ANTIBODIES TO A LYMPHOCYTE SURFACE RECEPTOR THAT BINDS CAML AND METHODS OF USE THEREOF
ANTIBODIES TO A MULTIDRUG RESISTANCE PROTEIN
ANTIBODIES TO A NEUTROPHIL CHEMOTACTIC PROTEIN
ANTIBODIES TO A NOVEL MAMMALIAN PROTEIN ASSOCIATED WITH UNCONTROLLED CELL DIVISION
ANTIBODIES TO A NOVEL SRC-FAMILY KINASE
ANTIBODIES TO A NOVEL TISSUE INHIBITOR OF METALLOPROTEINASES
ANTIBODIES TO A4 AMYLOID PEPTIDE
ANTIBODIES TO ADRENOMEDULLIN
ANTIBODIES TO ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR POLYPEPTIDES AND USES THEREFOR
ANTIBODIES TO AGLYCO PRODUCTS AND METHODS OF USE
ANTIBODIES TO ANGIOGENIN: IMMUNOTHERAPEUTIC AGENTS
ANTIBODIES TO APO(A)
ANTIBODIES TO ARF-P19
ANTIBODIES TO ARGATROBAN DERIVATIVES AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC TREATMENTS
ANTIBODIES TO BACTERIAL STRESS PROTEINS
ANTIBODIES TO BLADDER CANCER NUCLEAR MATRIX PROTEINS AND THEIR USE
ANTIBODIES TO BONE MORPHOGENETIC PROTEIN-10 (BMP-10)
ANTIBODIES TO C5 POLYPEPTIDES
ANTIBODIES TO CARDIAC HYPERTROPHY FACTOR AND USES THEREOF
ANTIBODIES TO CD40
ANTIBODIES TO CGMP-BINDING, CGMP-SPECIFIC PHOSPODIESTERASE
ANTIBODIES TO CLONED LEPTOSPIRA OUTER MEMBRANE PROTEIN AND USES THEREFORE
ANTIBODIES TO COMPLEXES OF LIGAND RECEPTORS AND LIGANDS AND THEIR UTILITY IN LIGAND-RECEPTOR ASSAYS
ANTIBODIES TO COMPONENTS OF DENSE MICROSPHERES AND METHODS OF USING THE SAME
ANTIBODIES TO CORPUSCLES OF STANNIUS PROTEIN, STANNIOCALCIN
ANTIBODIES TO CROSSLINKERS AND METHODS FOR USING THE SAME
ANTIBODIES TO CRYPTOSPORIDIUM
ANTIBODIES TO CYTOKINES IN THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE
ANTIBODIES TO CYTOKININS HAVING A GLYCOSYLATED ISOPRENOID SIDE CHAIN AND IMMUNOASSAY METHODS
ANTIBODIES TO DCR3 POLYPEPTIDE, A TNFR HOMOLOG
ANTIBODIES TO DENSE MICROSPHERES
ANTIBODIES TO DYSTROPHIN AND USES THEREFOR
ANTIBODIES TO EPITHELIUM-DERIVED T-CELL FACTOR
ANTIBODIES TO EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IGA
ANTIBODIES TO FAS-L FOR TREATMENT OF HEPATITIS
ANTIBODIES TO FLT4, A RECEPTOR TYROSINE KINASE AND USES THEREOF
ANTIBODIES TO FREE IGFBP-1
ANTIBODIES TO G PROTEIN COUPLED GLUTAMATE RECEPTORS
ANTIBODIES TO GROWTH DIFFERENTIATION FACTOR-12
ANTIBODIES TO HEPARAN SULFATE GLYCOSAMINOGLYCANS IN THE DIAGNOSIS OF POLYNEUROPATHIES
ANTIBODIES TO HER4, HUMAN RECEPTOR TYROSINE KINASE
ANTIBODIES TO HUMAN C5A RECEPTOR
ANTIBODIES TO HUMAN CARBOXYPEPTIDASE B AND METHODS OF USE THEREOF
ANTIBODIES TO HUMAN CARCINOMA ANTIGEN
ANTIBODIES TO HUMAN CK.BETA.-10/MCP-4
ANTIBODIES TO HUMAN CRIPTO PROTEIN
ANTIBODIES TO HUMAN CYSTATIN E
ANTIBODIES TO HUMAN G-PROTEIN CHEMOKINE RECEPTOR HDGNR10 (CCR5RECEPTOR)
ANTIBODIES TO HUMAN GASTRIN-RELEASING PEPTIDE PRECURSOR AND USE THEREOF
ANTIBODIES TO HUMAN GOOSE-TYPE LYSOZYME
ANTIBODIES TO HUMAN I-BRANCHING BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE
ANTIBODIES TO HUMAN IL-8 TYPE A RECEPTOR
ANTIBODIES TO HUMAN IL-8 TYPE B RECEPTOR
ANTIBODIES TO HUMAN KUNITZ-TYPE INHIBITOR
ANTIBODIES TO HUMAN NOTCH PROTEINS AND FRAGMENTS
ANTIBODIES TO HUMAN PAPILLOMAVIRUS LATENT PROTEINS, DIAGNOSTIC SYSTEMS AND METHODS
ANTIBODIES TO HUMAN PF4A RECEPTOR AND COMPOSITIONS THEREOF
ANTIBODIES TO HUMAN REDUCED FOLATE CARRIER PROTEIN
ANTIBODIES TO HUMAN TIE-2 LIGANDS
ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR TR10
ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR TR9
ANTIBODIES TO ICAM-2, AND FRAGMENTS THEREOF
ANTIBODIES TO ICAM-RELATED PROTEIN
ANTIBODIES TO IL-1.BETA.
ANTIBODIES TO IN VIVO ADVANCED GLYCOSYLATION ENDPRODUCTS
ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN IGFBP-6
ANTIBODIES TO INTEGRIN ALPHA SUBUNIT
ANTIBODIES TO INTERELEUKIN-1 ANTAGONISTS
ANTIBODIES TO INTERLEUKEN-7 RECEPTORS
ANTIBODIES TO INTERLEUKIN-1 .BETA. CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
ANTIBODIES TO INTERLEUKIN-1 RECEPTORS
ANTIBODIES TO INTERLEUKIN-4 RECEPTORS AND USES THEREOF
ANTIBODIES TO INTIMIN-LIKE PROTEINS OF E. COLI
ANTIBODIES TO ISLET AMYLOID POLYPEPTIDE (IAPP) AND SUBUNITS THEREOF
ANTIBODIES TO LEUKEMIA INHIBITORY FACTOR
ANTIBODIES TO LEUKEMIA INHIBITORY FACTOR AND THEIR USE IN IMMUNOASSAYS
ANTIBODIES TO LGE.SUB.2 -PROTEIN ANTIGENS
ANTIBODIES TO LIGAND ANALOGUES AND THEIR UTILITY IN LIGAND-RECEPTOR ASSAYS
ANTIBODIES TO LIGAND GROWTH FACTORS
ANTIBODIES TO LIGANDS FOR HEK4 RECEPTORS
ANTIBODIES TO LIPOCALIN HOMOLOGS
ANTIBODIES TO LIPOPROTEINS AND APOLIPOPROTEINS AND METHODS OF USE THEREOF
ANTIBODIES TO LIVER DERIVED RECEPTORS FOR ADVANCED GLYCOSYLATION ENDPRODUCTS AND USES THEREFOR
ANTIBODIES TO LYMPHOCYTE ACTIVATION ANTIGENS AND USES THEREFOR
ANTIBODIES TO MACROPHAGE STIMULATING PROTEIN, BIOASSAY AND IMMUNOPURIFICATION METHOD
ANTIBODIES TO MAMMALIAN ADIPOGENIC FACTORS
ANTIBODIES TO MAMMALIAN NK ANTIGENS AND USES
ANTIBODIES TO MAMMALIAN T CELL SURFACE ANTIGEN
ANTIBODIES TO MCH2, AN APOPTOTIC CYSTEINE PROTEASE
ANTIBODIES TO MCH6 POLYPEPTIDES
ANTIBODIES TO MDC PROTEINS
ANTIBODIES TO MENINGOCOCCAL POLYSACCHARIDE CONJUGATE VACCINES
ANTIBODIES TO MOTILIN HOMOLOGS
ANTIBODIES TO NATURAL KILLER CELL AND NON-SPECIFIC CYTOTOXIC CELL RECEPTOR AND TARGET CELL ANTIGENS
ANTIBODIES TO NATURAL KILLER STIMULATORY FACTOR
ANTIBODIES TO NEUROTROPHIC FACTOR-4 (NT-4)
ANTIBODIES TO NEUTROKINE-ALPHA
ANTIBODIES TO NIMA INTERACTING PROTEINS
ANTIBODIES TO NUCLEAR MATRIX PROTEINS
ANTIBODIES TO OCCLUDIN PROTEINS
ANTIBODIES TO OSTEOGENIC PROTEINS
ANTIBODIES TO OXIDATION-SPECIFIC EPITOPES ON LIPOPROTEIN AND METHODS FOR THEIR USE IN DETECTING, MONITORING AND INHIBITING THE GROWTH OF ATHEROMA
ANTIBODIES TO P-SELECTIN AND THEIR USES
ANTIBODIES TO P-SELECTIN GLYCOPROTEIN LIGAND
ANTIBODIES TO P40
ANTIBODIES TO PEPTIDES HAVING NGF-LIKE ACTIVITY, AND USE THEREOF
ANTIBODIES TO PEPTIDES HAVING NGF-LIKE ACTIVITY, SAID ANTIBODIES HAVING NO SUBSTANTIAL CROSS-REACTIVITY WITH NGF, AND USE THEREOF
ANTIBODIES TO PEPTIDES THAT TARGET GIT RECEPTORS AND RELATED METHODS
ANTIBODIES TO PEPTIDES UNIQUE TO SPECIFIC KERATIN PROTEINS
ANTIBODIES TO PF4A RECEPTOR
ANTIBODIES TO PIGR STALK
ANTIBODIES TO PLASMODIUM FALCIPARUM
ANTIBODIES TO POLYPEPTIDES HAVING PRENYLCYSTEINE CARBOXYL METHLYTRANSFERASE ACTIVITY OR INHIBITING ACTIVITY
ANTIBODIES TO PROTEIN, FAF1
ANTIBODIES TO RECEPTOR FOR ONCOSTATIN M
ANTIBODIES TO RECEPTORS FOR HUMAN INTERLEUKIN-12
ANTIBODIES TO S. MUTANS AND USES THEREOF
ANTIBODIES TO SECRETED PROTEIN HCEJQ69
ANTIBODIES TO SICAM-1
ANTIBODIES TO SMDF
ANTIBODIES TO SPECIFIC REGIONS OF CYCLOSPORINE RELATED COMPOUNDS
ANTIBODIES TO SUPEROXIDE DISMUTASE-4
ANTIBODIES TO THE ANTIGEN CAMPATH-1
ANTIBODIES TO THE CELL DIVISION PROTEIN SPA-1
ANTIBODIES TO THE CYTOPLASMIC DOMAIN OF THE THROMBOPOIETIN RECEPTOR
ANTIBODIES TO THE DEATH DOMAIN MOTIFS OF REGULATORY PROTEINS
ANTIBODIES TO THE HEPATOCELLULAR CARCINOMA ONCOGENE AND IMMUNOASSAYS USING THE SAME
ANTIBODIES TO THE HRPII PROTEIN OF PLASMODIUM FALCIPARUM
ANTIBODIES TO THE IL-17 RECEPTOR
ANTIBODIES TO THE LIPOPOLYSACCHARIDE BONDING OPSONIN SEPTIN
ANTIBODIES TO THE NEUROTROPHIC FACTOR NNT-1
ANTIBODIES TO THE OB RECEPTOR
ANTIBODIES TO THE RECEPTOR PROTEIN DESIGNATED 2F1
ANTIBODIES TO THE SLAM PROTEIN EXPRESSED ON ACTIVATED T CELLS
ANTIBODIES TO TISSUE FACTOR INHIBITOR
ANTIBODIES TO TNF BINDING PROTEIN I
ANTIBODIES TO TRUNCATED VEGF-D AND THEREOF
ANTIBODIES TO TRUNCATED VEGF-D AND USES THEREOF
ANTIBODIES TO VASCULAR ENDOTHELIAL CELL GROWTH FACTOR
ANTIBODIES TO VERTEBRATE SERRATE PROTEINS AND FRAGMENTS
ANTIBODIES TO VERTEBRATE SMOOTHENED PROTEINS
ANTIBODIES TO VIRAL ENCODED SEMAPHORIN PROTEIN RECEPTOR POLYPEPTIDES
ANTIBODIES WHICH ACTIVATE AN ERYTHROPOIETIN RECEPTOR
ANTIBODIES WHICH BIND A SUBPOPULATION OF MAC-1 (CD11B/CD18) MOLECULES WHICH MEDIATE NEUTROPHIL ADHESION TO ICAM-1 AND FIBRINOGEN
ANTIBODIES WHICH BIND AN ISOLATED 55 TO 75 KDA PROTEIN WHICH BINDS TO PRION PROTEIN
ANTIBODIES WHICH BIND GRANULOCYTE-MACROPHANE COLONY-STIMULATING FACTOR RECEPTOR
ANTIBODIES WHICH BIND HUMAN COLLAPSIN
ANTIBODIES WHICH BIND MENINGITIS RELATED HOMOLOGOUS ANTIGENIC SEQUENCES
ANTIBODIES WHICH BIND MYCOBACTERIAL TUBERCULOSIS PROTEINS
ANTIBODIES WHICH BIND THE G-CSF RECEPTOR EXTRACELLUAR DOMAIN AND METHODS OF TREATMENT
ANTIBODIES WHICH BIND TO INSECT GUT PROTEINS AND THEIR USE
ANTIBODIES WHICH BIND TO MOLECULES CONTAINING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE OR SEVERAL EPITOPES CHARACTERISTIC OF A LIVER STAGE ANTIGEN PRODUCED BY P. FALCIPARUM IN HEPATOCYTES
ANTIBODIES WHICH BIND TO NOVEL LYMPHOKINE RELATED PEPTIDES
ANTIBODIES WHICH BIND TO NY-ESO-1 CANCER ASSOCIATED PROTEINS, AND HYBRIDOMAS WHICH PRODUCE THESE ANTIBODIES
ANTIBODIES WHICH IMMUNOREACT WITH LAPINE LIPOPOLYSACCHARIDE BINDING PROTEIN (LBP)
ANTIBODIES WHICH REACT WITH FIBRINOGEN FRAGMENTS E1, E2 AND E3 AND METHODS OF THEIR USE
ANTIBODIES WHICH RECOGNIZE AND BIND HUMAN VILLIN
ANTIBODIES WHICH SPECIFICALLY BIND A CANCER RELATED ANTIGEN | ANTIBODIES WHICH SPECIFICALLY BIND MAMMALIAN RECEPTORS FOR INTERLEUKIN-10 (IL-10)
ANTIBODIES WHICH SPECIFICALLY BIND MCL-1 POLYPEPTIDE
ANTIBODIES WHICH SPECIFICALLY BIND T CELL INDUCIBLE FACTORS (TIFS)
ANTIBODIES WHICH SPECIFICALLY BIND TO A NOVEL .KAPPA./.MU.-LIKE PROTEIN TYROSINEOSPATASE, PTP.LAMBDA., AND HYBRIDOMA CELL LINES PRODUCING THE SAME
ANTIBODIES WHICH SPECIFICALLY BIND TO HUMAN TUMOR-ASSOCIATED KAZAL INHIBITOR-LIKE POLYPEPTIDE
ANTIBODIES WHICH SPECIFICALLY BIND TO PROTEINS HAVING TYROSINE KINASE ACTIVITY, WHEREIN SAID PROTEINS HAVE MORE THAN ONE TYROSINE KINASE DOMAIN, AND NO SH2 DOMAINS
ANTIBODIES WHICH SPECIFICALLY BIND TO THE THYMOKINE LYMPHOTACTIN
ANTIBODIES WHICH TARGET A NEUTRALIZATION SITE WITHIN THE SECOND VARIABLE REGION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GP120
ANTIBODIES WITH ALTERED EFFECTOR FUNCTIONS
ANTIBODIES WITH BINDING AFFINITY FOR THE CD3 ANTIGEN
ANTIBODIES WITH INCREASED BINDING AFFINITY
ANTIBODIES WITH REDUCED NET POSITIVE CHARGE
ANTIBODIES WITH SPECIFICITY FOR A COMMON EPITOPE ON E-SELECTIN AND L-SELECTIN
ANTIBODIES, AND METHODS FOR THEIR USE
ANTIBODIES, DIAGNOSTIC SYSTEMS AND METHODS FOR ASSAYING HBXAG
ANTIBODIES, DIAGNOSTIC SYSTEMS AND METHODS FOR ASSAYING SV40 HBXAG
ANTIBODIES, METHOD OF PREPARING SAME, OLIGOSACCHARIDES AND CLONES FOR PROVIDING SAID ANTIBODIES, AND THE USE OF SAID ANTIBODIES FOR TUMOR DIAGNOSIS AND THERAPY
ANTIBODIES, PRODUCTION METHOD OF THE ANTIBODIES, HYBRIDOMAS WHICH PRODUCE THE ANTIBODIES, PRODUCTION METHOD OF THE HYBRIDOMAS AND ANTIGEN PROTEINS RECOGNIZED BY THE ANTIBODIES
ANTIBODIES, PRODUCTION METHOD OF THE ANTIBODIES, HYBRIDOMAS WHICH PRODUCE THE ANTIBODIES, PRODUCTION METHOD THE HYBIRDOMAS AND ANTIGEN PROTEINS RECOGNIZED BY THE ANTIBODIES
ANTIBODIES, THAT BIND TO HIV-2 TRANSMEMBRANE GLYCOPROTEIN HOMODIMER (GP 80)
ANTIBODY 103B2
ANTIBODY 4G8B4B12
ANTIBODY 67D2
ANTIBODY 97A6
ANTIBODY AGAINST A 3-AMINOPHENYLBORONIC-GLYCATED PROTEIN COMPLEX AND ITS USE IN AN IMMUNOASSAY
ANTIBODY AGAINST CARCIONEMBRYONIC ANTIGEN (CEA)
ANTIBODY AGAINST CLEAVAGE PRODUCT OR VIMENTIN
ANTIBODY AGAINST GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE AND USE THEREOF
ANTIBODY AGAINST HUMAN ENDOMETRIAL STROMAL CELL GLYCOPROTEIN
ANTIBODY AGAINST HUMAN INTERLEUKIN-5 RECEPTOR ALPHA CHAIN
ANTIBODY AGAINST HUMAN INTERLEUKIN-5-RECEPTOR .ALPHA. CHAIN
ANTIBODY AGAINST HUMAN MUCIN CORE PROTEIN AND METHOD OF PREPARING AND USING SAME
ANTIBODY AGAINST HYPOXIA PROTEINS
ANTIBODY AND ANTIBODY DERIVATIVE IMMUNOREAGENTS REACTIVE WITH A CONSERVED EPITOPE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP 120
ANTIBODY AND METHOD FOR DETECTING THE HUMAN HOMOLOG OF MAD2
ANTIBODY AND T CELL RECOGNITION SITES ON GLYCOPROTEINS COMPRISING THE GCI COMPLEX OF HUMAN CYTOMEGALOVIRUS
ANTIBODY ANTAGONISTS OF HUMAN INTERLEUKIN-4
ANTIBODY BV10A4H2 SPECIFIC FOR HUMAN FLT3/FLK2 RECEPTOR AND MYBRIDOMA
ANTIBODY CATALYSIS OF CYCLOHEXADIENONE REARRANGMENTS
ANTIBODY CATALYSIS OF ENANTIO- AND DIASTEREO-SELECTIVE ALDOL REACTIONS
ANTIBODY CLASS-SPECIFIC INTERFERENCE ELIMINATING REAGENT
ANTIBODY COATED CRYSTAL CHEMICAL SENSOR
ANTIBODY COMPOSITION FOR DEBULKING BLOOD AND BONE MARROW SAMPLES FROM CML PATIENTS
ANTIBODY COMPOSITION FOR ISOLATING HUMAN CELLS FROM HUMAN-MURINE CHIMERIC HEMATOPOIETIC CELL SUSPENSIONS
ANTIBODY COMPOSITIONS FOR PREPARING ENRICHED CELL PREPARATIONS
ANTIBODY COMPOSITIONS FOR PREPARING ENRICHED DENDRITIC CELL PREPARATIONS
ANTIBODY COMPOSITIONS FOR PREPARING ENRICHED MESENCHYMAL PROGENITOR PREPARATIONS
ANTIBODY COMPOSITIONS FOR SELECTIVELY INHIBITING VEGF
ANTIBODY COMPOSITIONS FOR THE DETECTION AND QUANTIFICATION OF WATER TREATMENT POLYMERS
ANTIBODY COMPOSITIONS TO HCV AND USES THEREOF
ANTIBODY CONJUGATE COMPOSITIONS FOR SELECTIVELY INHIBITING VEGF
ANTIBODY CONJUGATE FORMULATIONS FOR SELECTIVELY INHIBITING VEGF
ANTIBODY CONJUGATE KITS FOR SELECTIVELY INHIBITING VEGF
ANTIBODY CONJUGATE METHODS FOR SELECTIVELY INHIBITING VEGF
ANTIBODY CONJUGATES
ANTIBODY CONJUGATES REACTIVE WITH HUMAN CARCINOMAS
ANTIBODY CONJUGATES WITH MACROCYCLIC LIGANDS
ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED FC REGIONS
ANTIBODY CONSTRUCT
ANTIBODY CONTAINING SIALYL LEWIS X DETERMINANTS
ANTIBODY COVALENTLY BOUND FILM IMMUNOBIOSENSOR
ANTIBODY DELIVERY SYSTEM FOR BIOLOGICAL RESPONSE MODIFIERS
ANTIBODY DERIVATIVES FOR CONTROLLING GENE EXPRESSION
ANTIBODY DETECTION OF ANTIBODIES TO VIRAL PROTEINS IN SERUM
ANTIBODY DETECTION OF MISMATCH REPAIR PROTEINS
ANTIBODY DIRECTED AGAINST HIV-1 P25 ANTIGEN
ANTIBODY DRUG-CONJUGATES
ANTIBODY DTPA-TYPE LIGAND CONJUGATES
ANTIBODY FOR A HOMOLOG OF RAT ELASTASE IV DERIVED FROM HUMAN PANCREAS
ANTIBODY FOR A TOXIN ASSAY, AND METHOD OF OBTAINING SAME
ANTIBODY FOR HUMAN TRANSLATIONAL REGULATOR
ANTIBODY FORMULATION
ANTIBODY FRAGMENTS
ANTIBODY FRAGMENTS IN THERAPY
ANTIBODY HAVING BINDING SPECIFICITY FOR HUMAN OUABAIN
ANTIBODY HAVING BINDING SPECIFICITY TO PARATHYROID HORMONE RELATED PROTEIN (PTHRP) AND KIT COMPRISING THE SAME
ANTIBODY HETEROCONJUGATES AND BISPECIFIC ANTIBODIES FOR USE IN REGULATION OF LYMPHOCYTE ACTIVITY
ANTIBODY IMMUNOLOGICALLY REACTIVE WITH SERINE PROTEASE EOS
ANTIBODY IMMUNOREACTIVE WITH A HUMAN CYTOKINE DESIGNATED LERK-6
ANTIBODY MATRIX DEVICE AND METHOD FOR EVALUATING IMMUNE STATUS
ANTIBODY METHODS FOR SELECTIVELY INHIBITING VEGF
ANTIBODY METHODS FOR THE TREATMENT OF A HORMONE-MEDIATED DISEASE
ANTIBODY OF THE ANTI-PROLIFERATION DOMAIN OF HUMAN BCL-2
ANTIBODY PREPARATIONS SPECIFICALLY BINDING TO UNIQUE DETERMINANTS OF CEA ANTIGENS OR FRAGMENTS THEREOF AND USE OF THE ANTIBODY PREPARATIONS IN IMMUNOASSAYS
ANTIBODY PURIFICATION
ANTIBODY PURIFICATION METHOD
ANTIBODY REACTIVE TO HAMSTER IMMUNOGLOBULINS AND ASSAY USING SAME
ANTIBODY REAGENT FOR DETECTING DISSECTING AORTIC ANEURYSM AND USES THEREOF
ANTIBODY REAGENTS THAT IDENTIFY THE CARBOXY-TERMINAL PEPTIDE OF THE GTP-BINDING PROTEIN G.SUB.O
ANTIBODY REAGENTS THAT SPECIFICALLY BIND TO THE CARBOXYL-TERMINAL DECAPTIDE OF SPECIFIC GTP-BINDING PROTEINS
ANTIBODY RECOGNIZING A SMALL SUBSET OF HUMAN HEMATOPOIETIC CELLS
ANTIBODY RECOGNIZING ENDOTHELIAL CELL LIGAND FOR LEUKOCYTE CR3
ANTIBODY SELECTION METHODS USING CELL SURFACE EXPRESSED LIBRARIES
ANTIBODY SPECIFIC FOR .BETA.1.FWDARW.6 N-ACETYLGLUCOSAMININYLTRANSFERASE
ANTIBODY SPECIFIC FOR A PROTEIN TYROSINE PHOSPHATASE THAT LOCALIZES TO FOCAL ADHESIONS
ANTIBODY SPECIFIC FOR AN ISOLATED CHEMOTACTIC FACTOR FROM PATIENTS WITH ENDOMETRIOSIS
ANTIBODY SPECIFIC FOR H4-1BB
ANTIBODY SPECIFIC FOR HOMOGALACTURONAN
ANTIBODY SPECIFIC FOR HUMAN MYT1 AND DETECTION METHODS
ANTIBODY SUBSTANCES THAT BIND TO ICAM-RELATED PROTEIN
ANTIBODY TEACHING AID
ANTIBODY TESTING SYSTEM
ANTIBODY TESTING SYSTEM WITH REMOVABLE AIR GAP
ANTIBODY THAT BINDS TO CLUSTER W-4 POLYPEPTIDE OF HUMAN SMALL CELL LUNG CARCINOMA CELLS
ANTIBODY THAT RECOGNIZES PYRAZINE DERIVATIVE AND METHOD FOR MEASURING 1,2-DICARBONYL DERIVATIVE USING SAID ANTIBODY
ANTIBODY THAT SPECIFICALLY BINDS AN MCH4 POLYPEPTIDE
ANTIBODY THAT SPECIFICALLY BINDS TO THE CADHERIN-5 CELL ADHESION RECOGNITION SEQUENCE
ANTIBODY TO AMINOTERMINAL PROPEPTIDE OF TYPE 1 PROCOLLAGEN
ANTIBODY TO AMINOTERMINAL PROPEPTIDE OF TYPE 1 PROCOLLAGEN, AND ASSAY METHOD USING IT
ANTIBODY TO AND ASSAY FOR PEPTIDE LINKED-PYRIDINOLINE AS INDICATOR OF BONE RESORPTION LEVEL
ANTIBODY TO ANTIGEN SPECIFICALLY EXPRESSED ON THE SURFACE OF B CELLS AND HODGKIN'S CELLS
ANTIBODY TO CARBOXY-TERMINUS OF HUMAN HERPESVIRUS 6 IMMEDIATE EARLY PROTEIN
ANTIBODY TO CYTOKINE RESPONSE GENE 2(CR2) POLYPEPTIDE
ANTIBODY TO DNASE INVOLVED IN APOPTOSIS
ANTIBODY TO ERBB2 PROMOTER BINDING FACTOR
ANTIBODY TO HERPES VIRUS ENTRY RECEPTOR PROTEIN
ANTIBODY TO HUMAN ENDOKINE ALPHA AND METHODS OF USE
ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR
ANTIBODY TO HUMAN TESTIN AND METHODS OF MAKING AND USING
ANTIBODY TO IL-12 RECEPTOR
ANTIBODY TO INTERLEUKIN-12 RECEPTOR
ANTIBODY TO MACROPHAGE-DERIVED INFLAMMATORY MEDIATOR (MIP-1.ALPHA. AND MIP-1.BETA.)
ANTIBODY TO NOVEL HUMAN PHOSPHORYLASE KINASE GAMMA SUBUNIT
ANTIBODY TO OCULAR AND VAGINAL SURFACE EPITHELIUM
ANTIBODY TO OSTEOCLAST ALPHAVBETA3 NTEGRIN
ANTIBODY TO PNA/NUCLEIC ACID COMPLEXES
ANTIBODY TO SERINE PROTEASE PRECURSOR
ANTIBODY TO SMOOTH MUSCLE MYOSIN HEAVY CHAINS
ANTIBODY TO THE NEURAL CELL ADHESION MOLECULE AND METHODS OF USE
ANTIBODY TO THE SYNCYTIOTROPHOBLAST ANTIGEN R80K AND USE THEREOF
ANTIBODY TO TYPE-I COLLAGEN AMINO-TERMINAL TELOPEPTIDE
ANTIBODY TO TYPE-I COLLAGEN CARBOXY-TERMINAL TELOPEPTIDE
ANTIBODY TREATMENT FOR ADIPOSITY
ANTIBODY VARIANTS
ANTIBODY WHICH IS DIRECTED AGAINST AND INHIBITS COLLAGEN BINDING TO A VLA-1 EPITOPE AND USES THEREOF
ANTIBODY WHICH SPECIFICALLY BINDS TO ENDOTHELIAL-MONOCYTE ACTIVATING POLYPEPTIDE II
ANTIBODY/RECEPTOR TARGETING MOIETY FOR ENHANCED DELIVERY OF ARMED LIGAND
ANTIBODY-AMINODEXTRAN-PHYCOBILIPROTEIN CONJUGATES
ANTIBODY-BASED METHOD OF LOCALIZING ACTIVATED THROMBIN RECEPTORS
ANTIBODY-CATALYZED DEUTERATION, TRITIATION, DEDEUTERATION OR DETRITIATION OF CARBONYL COMPOUNDS
ANTIBODY-CONTAINING ORAL COMPOSITION FOR SUPPRESSION OF PERIODONTAL DISEASE
ANTIBODY-DRUG CONJUGATES
ANTIBODY-ENCODING RECOMBINANT DNA AND ITS USE
ANTIBODY-ENHANCED CHEMILUMINESCENCE REACTIONS
ANTIBODY-ENHANCED STEREOSPECIFIC HYDROLYSES
ANTIBODY-INDUCED APOPTOSIS
ANTIBODY-MEDIATED AND LIGAND-MEDIATED TARGETING OF DIFFERENTIATION-INDUCERS TO TUMOR CELLS
ANTIBODY-MEDIATED COFACTOR-DRIVEN REACTIONS
ANTIBODY-MEDIATED DOWN-REGULATION OF PLANT PROTEINS
ANTIBODY-MEDIATED JUXTAPOSITION OF REACTIVE MOIETIES
ANTIBODY-MEDIATED REDUCTION OF .ALPHA.-KETOAMIDES
ANTIBODY-THROMBOLYTIC AGENT PRODUCT AND METHOD OF USE
ANTIBOW DEVICE FOR LASERS
ANTIBUCKLING CLAMSHELL PACKAGE
ANTICACHECTIC COMPOSITION
ANTICALCIFICATION TREATMENT FOR ALDEHYDE-TANNED BIOLOGICAL TISSUE
ANTICALCIFICATION TREATMENTS FOR FIXED BIOMATERIALS
ANTICALCULUS COMPOSITION
ANTICALCULUS DENTIFRICE COMPOSITION CONTAINING HIGHLY SOLUBLE PYROPHOSPHATE
ANTICALCULUS DENTIFRICES
ANTICALCULUS ORAL COMPOSITION
ANTICALCULUS ORAL COMPOSITION CONTAINING COMBINATIONS OF ORGANOPHOSPHORUS POLYCARBOXYLATE COTELOMERS AND INORGANIC POLYPHOSPHATE SALTS
ANTICALCULUS ORAL COMPOSITIONS
ANTICALCULUS ORAL COMPOSITIONS CONTAINING COMBINATIONS OF POLYMERS
ANTICANCER (IV) COMPLEXES FOR ORAL ADMINISTRATION AND A METHOD OF MAKING THE SAME
ANTICANCER ACTIVITY OF IMINO ACID CONJUGATES OR METHYLGLYOXAL
ANTICANCER AGENT
ANTICANCER AGENTS
ANTICANCER AGENTS BASED ON PREVENTION OF PROTEIN PRENYLATION
ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS
ANTICANCER ANTIBIOTIC MI43-37F11 SUBSTANCE
ANTICANCER COMPOSITION COMPRISING A DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVE
ANTICANCER COMPOUND AND ENANTIOMER SEPARATION METHOD USEFUL FOR SYNTHESIZING SAID COMPOUND
ANTICANCER COMPOUNDS AND METHODS
ANTICANCER COMPOUNDS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ANTICANCER CONJUGATES OF CAMPTOTHECIN AND UNSATURATED FATTY ACIDS
ANTICANCER EFFECTS OF SPECIFIC BRANCHED-CHAIN FATTY ACIDS AND RELATED PRODUCTION PROCESS
ANTICANCER ENTERAL FEEDING COMPOSITION
ANTICANCER PROPERTY OF DITHIOLOPYRROLONES
ANTICANCER TREATMENT USING TRIPTOLIDE PRODRUGS
ANTICARCINOGENIC DRUG COMPOSITION
ANTICARIES COMPOSITIONS
ANTICARIOGENIC DAIRY PRODUCT AND ITS USE
ANTICATARACT COMPOSITION
ANTICENTRIFUGAL ACTIVE LATERAL SUSPENSION FOR RAILWAY VEHICLES
ANTICHAFING STRIP FOR SHAVING EQUIPMENT HEAD AND SHAVING EQUIPMENT HEAD COMPRISING SAME
ANTICHOLESTATIC EFFECT OF LUTEOLIN
ANTICHOLESTEREMIC COMPOUNDS
ANTICHOLESTEROLEMIC EDIBLE OIL
ANTICHOLINERGIC AGENTS
ANTICHOLINERGIC COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT
ANTICHOLINERGIC COMPOUNDS, COMPOSITITONS AND METHODS OF TREATMENT
ANTICHOLINERGICS WHICH MAY BE USED AS MEDICAMENTS AS WELL AS PROCESSES FOR PREPARING THEM
ANTICHOLINERGICS, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS
ANTICIPATED MEANING NATURAL LANGUAGE INTERFACE
ANTICIPATING CACHE MEMORY LOADER AND METHOD
ANTICIPATORY AUTOMATIC GAIN CONTROL CIRCUIT
ANTICIPATORY CALL DISTRIBUTOR
ANTICIPATORY COLLISION SENSOR SYSTEM
ANTICIPATORY INTAKE MANIFOLD TUNING VALVE CONTROL
ANTICIPATORY INTERACTIVE PROTECTIVE SYSTEM
ANTICIPATORY LOCK MODE CONVERSIONS IN A LOCK MANAGEMENT SYSTEM
ANTICIPATORY OPTIMIZATION WITH COMPOSITE FOLDING
ANTICIPATORY SCHMITT TRIGGER
ANTICLOGGING WATER JET CRAFT
ANTICLOTTING DEVICE AND METHOD FOR USE WITH IV CATHETERS
ANTICLUMPING COMPOSITION AND ANTICLUMPING PROCESS FOR FERTILIZERS
ANTICOAGULANT AGENTS
ANTICOAGULANT ANALOGUES OF THE TISSUE FACTOR EXTRINSIC PATHWAY INHIBITOR (EPI) WITH REDUCED AFFINITY FOR HEPARIN
ANTICOAGULANT AND HEMANALYSIS METHOD
ANTICOAGULANT COMBINATION OF LACI AND SULFATED POLYSACCHARIDES
ANTICOAGULANT COMPOSITION
ANTICOAGULANT COMPOSITION FOR USE IN BLOOD DIALYSIS CIRCUIT
ANTICOAGULANT COMPOSITIONS
ANTICOAGULANT FUSION PROTEIN ANCHORED TO CELL MEMBRANE
ANTICOAGULANT HIRUDIN VARIANTS AND METHODS FOR THEIR PRODUCTION
ANTICOAGULANT INTERNALLY COATED NEEDLE
ANTICOAGULANT PEPTIDE ALDEHYDE DERIVATIVES
ANTICOAGULANT PEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS WELL AS A PROCESS FOR PREPARATION THEREOF
ANTICOAGULANT PEPTIDE FRAGMENTS DERIVED FROM APOLIPOPROTEIN B-100
ANTICOAGULANT PEPTIDES
ANTICOAGULANT PEPTIDYL-ARGININE ALDEHYDE DERIVATIVES
ANTICOAGULANT PLASMA POLYMER-MODIFIED SUBSTRATE
ANTICOAGULANT SOLUTION FOR USE IN BLOOD CHEMISTRY-RELATED TECHNIQUES AND APPARATUS
ANTICOAGULANT SUBSTANCE OBTAINED FROM URINE
ANTICOAGULANT SUBSTANCE OBTAINED FROM URINE AND PROCESS FOR THE PREPARATION THEREOF
ANTICOAGULANT TEST
ANTICOAGULANT/SURFACTANT RODENTICIDAL COMPOSITIONS AND METHOD
ANTICOAGULATIVE PROTEIN PP4-X
ANTICOCCIDIAL AND GROWTH PROMOTING POLYCYCLIC ETHER ANTIBIOTIC
ANTICOCCIDIAL COMBINATIONS COMPRISING NICARBAZIN AND SEMDURAMICIN
ANTICOCCIDIAL COMPOSITION OF UK-61 689 AND ACTINOMADURA MYCELIUM
ANTICOCCIDIAL COMPOSITIONS
ANTICOCCIDIAL COMPOUNDS
ANTICOCCIDIAL METHOD
ANTICOCCIDIAL METHODS
ANTICOCCIDIAL METHODS AND FEEDSTUFFS
ANTICOLLISION DEVICE FOR DRIVERLESS INDUSTRIAL TRUCKS
ANTICOLLISION DEVICE, NOTABLY FOR MOTOR VEHICLES
ANTICOLLISION PROTOCOL FOR READING MULTIPLE RFID TAGS
ANTICOLLISION SYSTEM FOR OBJECTIVE LENS IN AN OPTICAL DATA RECORDING APPARATUS
ANTICOMPLEMENT ACTIVITY ASSAYS
ANTICONVULSANT AND ANXIOLYTIC LACTAM AND THIOLACTAM DERIVATIVES
ANTICONVULSANT AND CENTRAL NERVOUS SYSTEM-DEPRESSING BIS(FLUOROPHENYL)ALKYLAMIDES AND THEIR USES
ANTICONVULSANT CONTAINING COMPOSITION FOR TREATING NEUROPATHIC PAIN
ANTICONVULSANT DERIVATIVES USEFUL FOR THE TREATMENT OF DEPRESSION
ANTICONVULSANT DERIVATIVES USEFUL IN LOWERING BLOOD PRESSURE
ANTICONVULSANT DERIVATIVES USEFUL IN LOWERING LIPIDS
ANTICONVULSANT DERIVATIVES USEFUL IN REDUCING BLOOD GLUCOSE LEVELS | ANTICONVULSANT DERIVATIVES USEFUL IN TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING AUTISM
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING CHRONIC NEURODEGENERATIVE DISORDERS
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING CLUSTER HEADACHES
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING DEMENTIA
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING ESSENTIAL TREMOR
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING MANIC-DEPRESSIVE BIPOLAR DISORDER
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING NEUROPATHIC PAIN
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING OBESITY
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING POST TRAUMATIC STRESS DISORDER
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING PSORIASIS
ANTICONVULSANT DERIVATIVES USEFUL IN TREATING PSYCHOSIS
ANTICONVULSANT DRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF
ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES
ANTICONVULSANT FRUCTOPYRANOSE CYCLIC SULFITES AND SULFATES
ANTICONVULSANT PSEUDOFRUCTOPYRANOSE SULFAMATES
ANTICONVULSANT PYRIDINYL BENZAMIDE DERIVATIVES
ANTICONVULSANT SORBOPYRANOSE SULFAMATES
ANTICONVULSANT SUBSTITUTED QUINAZOLONES
ANTICONVULSIVE 1-AR(ALK)YLIMIDAZOLIN-2-ONES AND PROCESS FOR MAKING
ANTICONVULSIVE AGENTS AND USES THEREOF
ANTICONVULSIVE AND ANTIALLERGIC/ANTIASTHMATIC PYRAZOLO-[3,4-D]PYRIMIDINES, AND PROCESS FOR PREPARING
ANTICONVULSIVE IMIDAZOLINE-2,4-DIONES AND PROCESS FOR MAKING
ANTICONVULSIVE SUBSTITUTED-9-BENZYL-9H-PURINES
ANTICOPYING FILM
ANTICORROSION AND PH STABLE ALKALI METAL HALIDE SOLUTIONS FOR AIR DEHUMIDIFICATION
ANTICORROSION BATTERY TERMINAL WITH SHORT ANCHORING, WITHOUT JOINT SEAMS
ANTICORROSION BINDERS COMPRISING PHOSPHATE OR PHOSPHONATE GROUPS
ANTICORROSION COATING COMPOSITION
ANTICORROSION TREATMENT
ANTICORROSION TREATMENT OF METAL COATED STEEL HAVING COATINGS OF ALUMINIUM, ZINC OR ALLOYS THEREOF
ANTICORROSIVE AGENT
ANTICORROSIVE AND ANTIFOULING ADDITIVE FOR PAINTS AND PAINT CONTAINING THE SAME
ANTICORROSIVE CATHODIC ELECTRODEPOSITION PAINT
ANTICORROSIVE COAT STRUCTURE OF LEAD
ANTICORROSIVE COATING COMPOSITION
ANTICORROSIVE COATING COMPOSITION AND ANTICORROSION TREATMENT METHOD
ANTICORROSIVE COATING MATERIAL AND METHOD OF RUST PREVENTION
ANTICORROSIVE LUBRICANT COMPOSITION FOR MOLDED PLASTIC PRODUCTS AND MOLDED PLASTIC PRODUCTS WITH SAME APPLIED THERETO
ANTICORROSIVE MAGNETIC NANOCOLLOIDS PROTECTED BY PRECIOUS METALS
ANTICORROSIVE METHOD OF STREAM AND CONDENSER SYSTEMS
ANTICORROSIVE MICROBICIDE
ANTICORROSIVE PIGMENT COMPOSITION AND COATING COMPOSITIONS CONTAINING THE SAME
ANTICORROSIVE PIGMENT PREPARATION CONTAINING METAL OXIDE-COATED PLATELET ADJUVANT
ANTICORROSIVE PIGMENTS ON THE BASIS OF TERTIARY ALKALINE-EARTH ALUMINUM PHOSPHATES AND A PROCESS FOR THE PRODUCTION THEREOF
ANTICORROSIVE PLASTIC PACKAGING MATERIALS
ANTICORROSIVE PRIMER COMPOSITION
ANTICORROSIVE SURFACE COATINGS
ANTICORROSIVE TREATMENT METHOD FOR A SEPARATOR OF MOLTEN CARBONATE FUEL CELL
ANTICOUNTERFEIT DEVICE FOR DISPENSER
ANTICOUNTERFEIT DOCUMENTATION WITH SEE-THROUGH AND WRITE-ABLE HOLOGRAM
ANTICOUNTERFEIT SECURITY DEVICE . . . INCLUDING TWO SECURITY ELEMENTS
ANTICOUNTERFEIT, LASER-MARKABLE LABEL PRODUCED BY DIFFRACTION GRATINGS
ANTICOUNTERFEITING DEVICE FOR GAMING CHIPS
ANTICOUNTERFEITING METHOD AND DEVICE UTILIZING HOLOGRAMS AND PSEUDORANDOM DOT PATTERNS
ANTICOUNTERMEASURE SYSTEM FOR TORPEDOES
ANTICRASH ARMOR-PLATED MODULAR SEAT
ANTICRATER AGENT COMPOSITIONS FOR USE IN CATHODIC ELECTROCOATING
ANTICROSS-THREADING MALE FASTENER
ANTICURL BACKING LAYER IN ELECTROSTATOGRAPHIC IMAGING MEMBERS
ANTICYCLONE POWERED ACTIVE THERMAL CONTROL UNIT
ANTICYTOMEGALOVIRUS MONOCLONAL ANTIBODIES AND PROCESSES FOR THE IN VITRO DIAGNOSIS OF INFECTIONS BY HUMAN CYTOMEGALOVIRUSES AND A PROTEIN-KINASE INDUCIBLE BY CYTOMEGALOVIRUSES AND RECOGNIZABLE BY AFORESAID MONOCLONAL ANTIBODIES
ANTIDANDRUFF AGENTS AND COSMETIC PREPARATIONS
ANTIDANDRUFF COMPOSITION FOR TREATING THE HAIR AND THE SCALP, BASED ON AN ANTIDANDRUFF AGENT AND AN ACRYLIC TERPOLYMER
ANTIDANDRUFF COMPOSITIONS
ANTIDANDRUFF SHAMPOO COMPOSITION HAVING IMPROVED SUSPENSION PROPERTIES
ANTIDANDRUFF SHAMPOO COMPOSITIONS
ANTIDECUBITUS IMMOBILIZATION CERVICAL COLLAR
ANTIDEPRESSANT 1-ARYLALKYL-4-(ALKOXY PYRIDINYL)-AND 4-(ALKOXYPYRIMIDINYL) PIPERAZINE DERIVATIVES
ANTIDEPRESSANT 3-(AMINOCYCLOALKENYL)-INDOLE-5-NITRILE DERIVATIVES
ANTIDEPRESSANT 3-HALOPHENYLPIPERAZINYLPROPYL DERIVATIVES OF SUBSTITUTED TRIAZOLONES AND TRIAZOLDIONES
ANTIDEPRESSANT AGENTS
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 1,4,5-TRIOXA-PHENANTHRENE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 1,4-DIOXINO[2,3-B]PYRIDINE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-F]QUINAZOLINE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-F]QUINOXALINE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINOL[2,3F]QUINOLINE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 7,8-DIHYDRO-1,6,9-TRIOXA-3-AZA-CYCLOPENTA[A]NAPHTHALENE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZACYCLOPENTA[A]NAPHTHALENE
ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF OXAHETEROCYCLE-FUSED-[1,4]-BENZODIOXANS
ANTIDEPRESSANT AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-BENZODIOXAN
ANTIDEPRESSANT AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO [2,3-F]QUINOLINE
ANTIDEPRESSANT CHROMAN AND CHROMENE DERIVATIVES OF 3-(1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE
ANTIDEPRESSANT DRUGS AND METHODS
ANTIDEPRESSANT EFFECT OF NOREPINEPHRINE UPTAKE 2 INHIBITORS AND COMBINED MEDICATIONS INCLUDING THEM
ANTIDEPRESSANT HETEROARYLAMINOALKYL DERIVATIVES OF NAPHTHYL-MONAZINES
ANTIDEPRESSANT HETEROCYCLIC COMPOUNDS
ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-E]INDOLE
ANTIDEPRESSANT POLYCYCLIC IMIDES TO TREAT DEPRESSION
ANTIDEPRESSANTS
ANTIDEPRESSIVE THERAPY
ANTIDETECTION BY RADAR DEVICE FOR A FLATTENED SUPERSTRUCTURE OF A SHIP
ANTIDIABETIC 4-HYDROXY-2-FUROIC ACIDS
ANTIDIABETIC AGENT AND METHOD OF TREATING DIABETES
ANTIDIABETIC AGENTS
ANTIDIABETIC AGENTS BASED ON ARYL AND HETEROARYLACETIC ACIDS
ANTIDIABETIC COMPOUNDS HAVING HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ANTIDIABETIC EXTERNAL SKIN APPLICATION COMPOSITION
ANTIDIABETIC FORMULATION AND METHOD
ANTIDIABETIC PIPERAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
ANTIDIARRHEAL COMPOSITIONS CONTAINING LAPERAMIDE HYDROCHLORIDE AND A SACCHARIDE
ANTIDIARRHEAL COMPOSITIONS CONTAINING LOPERAMIDE HYDROCHLORIDE AND A SACCHARIDE
ANTIDIOTYPIC MONOCLONAL ANTIBODIES FOR TREATMENT OF MELANOMA
ANTIDISSIPATION APPARATUS FOR EVAPORATED FUEL VAPOR
ANTIDOTE FOR HIRUDIN AND SYNTHETIC THROMBIN INHIBITORS AND METHOD OF USE
ANTIDOTING HERBICIDAL 3-ISOXAZOLIDINONE COMPOUNDS
ANTIDOTING HERBICIDAL 3-IXOXAZOLIDINONE COMPOUNDS
ANTIDRIP AGENTS FOR THERMOPLASTIC MOLDING COMPOUNDS
ANTIDROP PROTECTOR FOR SHEET-STACKING APPARATUS
ANTIEJECT DEVICE FOR CONTROL MEMBERS OF NUCLEAR REACTORS
ANTIEMETIC COMPOSITIONS
ANTIEMETIC THERAPY
ANTIEMETIC USE OF TRIAZOLO-PYRIDAZINE DERIVATIVES
ANTIEMULSION/ANTIFOAM AGENT FOR USE IN OILS
ANTIESTROGENS, PROCESS FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE
ANTIESTROGENS, PROCESS FOR THEIR PROTECTION AND THEIR PHARMACEUTICAL USE
ANTIFALSIFICATION PAPER
ANTIFALSIFICATION PAPER HAVING A THREAD- OR BAND-SHAPED SECURITY ELEMENT
ANTIFALSIFICATION PAPER HAVING A THREAD- OR BAND-SHAPED SECURITY ELEMENT AND A METHOD FOR PRODUCING IT
ANTIFERROELECTRIC LCD HAVING PARTICULAR RUBBING DENSITY AND PRETILT ANGLES
ANTIFERROELECTRIC LCD IN WHICH A NORMAL TO AN ANTIFERROELECTRIC LIQUID CRYSTAL LAYER IS ORTHOGONAL TO A NORMAL TO A SECOND ANTIFERROELECTRIC LIQUID CRYSTAL LAYER
ANTIFERROELECTRIC LIQUID CRYSTAL CELL
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOSITE MATERIAL, PROCESS FOR PREPARING THE SAME, AND LIQUID CRYSTAL ELEMENT USING THE SAME
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOSITION
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL INDICATING ELEMENT
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOUND
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOUND AND ANTIFERROELECTRIC LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME
ANTIFERROELECTRIC LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCING THE SAME
ANTIFERROELECTRIC LIQUID CRYSTAL DISPLAY
ANTIFERROELECTRIC LIQUID CRYSTAL DISPLAY AND METHOD OF DRIVING
ANTIFERROELECTRIC LIQUID CRYSTAL DISPLAY DEVICE
ANTIFERROELECTRIC LIQUID CRYSTAL DISPLAY ELEMENT AND DEVICE, AND METHOD OF DRIVING THE SAME
ANTIFERROELECTRIC LIQUID CRYSTAL DISPLAY ELEMENT EXHIBITING A PRECURSOR TILT PHENOMENON
ANTIFERROELECTRIC LIQUID CRYSTAL DISPLAY WITH LIQUID CRYSTAL LAYER STRUCTURE CONTROL
ANTIFERROELECTRIC LIQUID CRYSTAL LIGHT MODULATION DEVICE
ANTIFERROELECTRIC LIQUID CRYSTAL PANEL
ANTIFERROELECTRIC LIQUID CRYSTAL PANEL CAPABLE OF DISPLAYING IMAGES WITHOUT FLICKERING
ANTIFERROELECTRIC LIQUID CRYSTAL WITH POLARIZING AXES ORIENTED BETWEEN A MOLECULAR AXIS DIRECTION IN RIGHTWARD-TILTED ANTIFERROELECTRIC STATE AND A MOLECULAR AXIS DIRECTION IN LEFTWARD-TILTED ANTIFERROELECTRIC STATE
ANTIFERROLECTRIC LIQUID CRYSTAL PANEL AND METHOD FOR DRIVING SAME
ANTIFERROMAGNETIC EXCHANGE BIASING USING BUFFER LAYER
ANTIFERROMAGNETIC EXCHANGE COUPLING IN MAGNETORESISTIVE SPIN VALVE SENSORS
ANTIFERROMAGNETIC FILM SUPERIOR IN CORROSION RESISTANCE, MAGNETORESISTANCE-EFFECT ELEMENT AND MAGNETORESISTANCE-EFFECT HEAD INCLUDING SUCH THIN FILM
ANTIFERROMAGNETICALLY COUPLED MAGNETIC RECORDING MEDIA WITH BORON-FREE FIRST FERROMAGNETIC FILM AS NUCLEATION LAYER
ANTIFERROMAGNETICALLY COUPLED MAGNETIC RECORDING MEDIUM WITH DUAL-LAYERED UPPER MAGNETIC LAYER
ANTIFERROMAGNETICALLY COUPLED THIN FILMS FOR MAGNETIC RECORDING
ANTIFERROMAGNETICALLY EXCHANGE-COUPLED STRUCTURE FOR MAGNETIC TUNNEL JUNCTION DEVICE
ANTIFERROMAGNETICALLY STABILIZED PSEUDO SPIN VALVE FOR MEMORY APPLICATIONS
ANTIFLAMMATORY QUINOLIN METHOXY PHENYLSULPHONAMIDES
ANTIFLATULENT COMPOSITION
ANTIFLECTOR BLACK MATRIX HAVING SUCCESSIVELY A CHROMIUM OXIDE LAYER, A MOLYBDENUM LAYER AND A SECOND CHROMIUM OXIDE LAYER
ANTIFOAM BEVERAGE STIRRER OR STRAW
ANTIFOAM COMPOSITION FOR AQUEOUS STARCH AND PAPER COATING SYSTEMS
ANTIFOAM COMPOSITION FOR AQUEOUS SYSTEMS
ANTIFOAM COMPOSITIONS
ANTIFOAM COMPOSITIONS AND INTERMEDIATE ANHYDROUS COMPOSITIONS
ANTIFOAM COMPOSITIONS FOR VEGETABLE EXTRACTS
ANTIFOAM COMPOSITIONS INCLUDING LECITHIN AND USES THEREOF
ANTIFOAM FORMULATION
ANTIFOAM/DEFOAMER COMPOSITION AND METHOD OF USE THEREOF IN AQUEOUS SYSTEMS
ANTIFOAM/DEFOAMER COMPOSITIONS FOR BAYER PROCESS
ANTIFOAMING AGENT AND CANNED DRINK USING THE SAME
ANTIFOAMING AGENT COMPOSITION FOR A SILVER HALIDE PHOTOGRAPHIC PROCESSING SOLUTION AND PROCESS FOR PROCESSING A SILVER HALIDE PHOTOGRAPHIC MATERIAL USING SAME
ANTIFOAMING AGENT FOR FERMENTATION AND FERMENTATION PRODUCTION PROCESS USING THE SAME
ANTIFOAMING AGENT FOR FERMENTATION, L-AMINO ACID-PRODUCING MEDIUM AND PRODUCTION PROCESS OF L-AMINO ACIDS
ANTIFOAMING AGENT FOR FOOD AND FOOD MATERIAL CONTAINING THE SAME
ANTIFOAMING AGENTS
ANTIFOAMING AGENTS FOR LUBRICATING OILS (LAW455)
ANTIFOAMING COMPOSITIONS
ANTIFOAMING COMPOSITIONS AND INTERMEDIATE ANHYDROUS COMPOSITIONS
ANTIFOAMING DEVICE AND METHOD FOR EXTRACORPOREAL BLOOD PROCESSING
ANTIFOAMS BASED ON OIL-IN-WATER EMULSIONS FOR THE PAPER INDUSTRY
ANTIFOAMS FOR SOLID CROP PROTECTION AGENTS
ANTIFOAMS FOR THE PAPER INDUSTRY, BASED ON OIL-IN-WATER EMULSIONS
ANTIFOG COMPOSITION FOR POLYOLEFIN PACKAGING FILMS
ANTIFOG FILM LAMINATES
ANTIFOG/BARRIER LAMINATE FOR USE IN MEAT PACKAGING
ANTIFOGGANTS FOR PHOTOTHERMOGRAPHIC ARTICLES
ANTIFOGGING ABRASION RESISTANT COATING COMPOSITION AND SYNTHETIC RESIN ARTICLE COATED THEREWITH
ANTIFOGGING PLASTIC LENS MATERIAL
ANTIFORGERY SECURITY SYSTEM
ANTIFORM DELIVERY SYSTEM
ANTIFOULANT COMPOSITION COMPRISING AN ACRYLATE ESTER CONTAINING C.SUB.4 -C.SUB.22 ALCOHOL ESTERS AND AMINO ALCOHOL ESTERS AND PHENYLENE DIAMINE
ANTIFOULANT COMPOSITIONS AND METHODS OF TREATING WOOD
ANTIFOULANT COMPOSITIONS AND PROCESSES
ANTIFOULANT CONTROL PROCESS
ANTIFOULANT FOR ACRYLIC ACID PURIFICATION
ANTIFOULANT FOR ACRYLONITRILE PURIFICATION
ANTIFOULANT FOR INORGANIC FOULING
ANTIFOULING AGENT
ANTIFOULING AGENTS, THEIR PRODUCTION AND USE, AND ANTIFOULING COATING PRODUCED THEREFROM
ANTIFOULING COATING
ANTIFOULING COATING AND METHOD FOR USING SAME
ANTIFOULING COATING COMPOSITION
ANTIFOULING COATING COMPOSITION COMPRISING FURAN COMPOUNDS, METHOD FOR PROTECTING AQUATIC STRUCTURES, AND ARTICLES PROTECTED AGAINST FOULING ORGANISMS
ANTIFOULING COATING COMPOSITION COMPRISING LACTONE COMPOUNDS, METHOD FOR PROTECTING AQUATIC STRUCTURES, AND ARTICLES PROTECTED AGAINST FOULING ORGANISMS
ANTIFOULING COATING COMPOSITION, COATING FILM FORMED FROM SAID ANTIFOULDING COATING COMPOSITION, ANTIFOULING METHOD USING SAID ANTIFOULING COATING COMPOSITION AND HULL OR UNDERWATER STRUCTURE COATED WITH SAID COATING FILM
ANTIFOULING COATING COMPOSITION, COATING FILM FORMED FROM SAID ANTIFOULING COATING COMPOSITION, ANTIFOULING METHOD USING SAID ANTIFOULING COATING COMPOSITION AND HULL OR UNDERWATER STRUCTURE COATED WITH SAID COATING FILM
ANTIFOULING COATING COMPOSITIONS
ANTIFOULING COATINGS
ANTIFOULING COMPOSITION
ANTIFOULING COMPOSITION USING ALKYL-PHENOLS
ANTIFOULING COMPOSITION, METHOD FOR ITS PRODUCTION AND PRODUCT TREATED THEREWITH
ANTIFOULING COMPOSITIONS
ANTIFOULING COMPOSITIONS CONTAINING THIACLOPRID
ANTIFOULING INFRARED SHIELDING FILM AND PROCESS FOR PRODUCING THE SAME
ANTIFOULING MARINE COATINGS
ANTIFOULING MEMBER AND ANTIFOULING COATING COMPOSITION
ANTIFOULING MEMBER AND PROCESS FOR PRODUCING THE SAME
ANTIFOULING OF SHELLFISH AND AQUACULTURE APPARATUS
ANTIFOULING PAINT
ANTIFOULING PAINT COMPOSITION
ANTIFOULING PAINT COMPOSITIONS
ANTIFOULING PAINTS
ANTIFOULING POLYMERS
ANTIFOULING RESINOUS COMPOSITION AND METHOD FOR PRODUCTION THEREOF
ANTIFOULING SILICONE EMULSION COATING-COMPOSITION, PROCESS FOR PRODUCING THE SAME AND ANTIFOULING ARTICLE COATED THEREWITH
ANTIFOULING STRUCTURE AND METHOD
ANTIFOULING STRUCTURE HAVING EFFECT OF PREVENTING ATTACHMENT OF AQUATIC ORGANISMS THERETO
ANTIFOULING STRUCTURES
ANTIFOULING SYSTEM FOR STRUCTURE EXPOSED TO SEAWATER AND HEAT EXCHANGER
ANTIFOULING WALL STRUCTURE FOR USE IN PIPE AND METHOD OF CONSTRUCTING THE ANTIFOULING WALL THEREFOR
ANTIFOULING WALL STRUCTURE, METHOD OF CONSTRUCTING ANTIFOULING WALL AND ANTIFOULING WALL PANEL TRANSPORTER THEREFOR
ANTIFOULING/ANTICORROSIVE COMPOSITE MARINE STRUCTURE
ANTIFRACTURE SCORES FOR EASY OPEN CONTAINER WALLS
ANTIFRAGMENTATION PLATES BASED ON ACRYLIC POLYMERS
ANTIFRAGMENTATION PLATES OF POLYMETHYLMETHACRYLATE
ANTIFRAUD CREDIT CARD ASSEMBLY
ANTIFRAUD CURRENCY ACCEPTOR
ANTIFREEZE ADMIXTURE FOR CONCRETE
ANTIFREEZE AND DE-ICING AGENT, ESPECIALLY FOR THE DE-ICING OF SURFACES
ANTIFREEZE CAP FOR FAUCET
ANTIFREEZE CIRCULATING DEVICE
ANTIFREEZE COMPOSITION
ANTIFREEZE COMPOSITION COMPRISING A WATER-SOLUBLE ALCOHOL AND A CORROSION INHIBITOR SYSTEM COMPRISING DICARBOXYLIC ACIDS OR SALTS THEREOF, DIAZOLE AND A TRIAZOLE
ANTIFREEZE COMPOSITION CONTAINING POLY (OXYALKYLENE) -SUBSTITUTED COLORANT
ANTIFREEZE COMPOSITIONS AND USES
ANTIFREEZE COMPOSITIONS COMPRISING CARBOXYLIC ACID AND CYCLOHEXENOIC ACID
ANTIFREEZE CONCENTRATE INCLUDING ALKOXYBENZOIC ACID
ANTIFREEZE CONCENTRATES AND COMPOSITIONS COMPRISING NEODECANOIC ACID CORROSION INHIBITORS
ANTIFREEZE CONCENTRATES AND COOLANT COMPOSITIONS CONTAINING THESE CONCENTRATES FOR COOLING CIRCUITS IN INTERNAL COMBUSTION ENGINES
ANTIFREEZE FORMULATION CONTAINING PHOSPHOROUS ACID
ANTIFREEZE GEL COMPOSITION FOR USE IN A CABLE CONDUIT
ANTIFREEZE POLYPEPTIDE-EXPRESSING MICROORGANISMS USEFUL IN FERMENTATION AND FREEZING OF FOODS
ANTIFREEZE POLYPEPTIDE-EXPRESSING MICROORGANISMS USEFUL IN FERMENTATION AND FROZEN STORAGE OF FOODS
ANTIFREEZE PURIFICATION
ANTIFREEZE RECLAMATION SYSTEM AND PROCESS
ANTIFREEZE SYSTEM FOR INSTANT WATER HEATERS
ANTIFREEZE/COOLANT COMPOSITION
ANTIFREEZE/COOLANT COMPOSITION CONTAINING CINNAMIC ACID
ANTIFREEZE/COOLANT COMPOSITION CONTAINING P-TOLUATE AND A MOLYBDATE
ANTIFREEZE/COOLANT REPLACEMENT KIT
ANTIFRETTING COATING FOR A BUSHING IN A COLDWORKED JOINT
ANTIFRICTION BEARING
ANTIFRICTION BEARING AND ALTERNATOR INCORPORATING SAME FOR USE IN VEHICLES
ANTIFRICTION BEARING ASSEMBLY SPEED SENSOR
ANTIFRICTION BEARING CAPABLE OF GENERATING ELECTRIAL ENERGY
ANTIFRICTION BEARING FASTENING ARRANGEMENT
ANTIFRICTION BEARING FOR USE IN APPARATUS FOR DAMPING FLUCTUATIONS OF TORQUE IN POWER TRAINS OF MOTOR VEHICLES
ANTIFRICTION BEARING INCLUDING MICROSENSOR FOR DETERMINING PARAMETERS, IN PARTICULAR WHEEL BEARING FOR MOTOR VEHICLES
ANTIFRICTION BEARING PRE-LOADING DEVICE AND SHAFT BEARING STRUCTURE
ANTIFRICTION BEARING WITH A CLIP-ON SENSOR
ANTIFRICTION BEARING WITH A SEAL LOCKED AGAINST ROTATION
ANTIFRICTION BEARING WITH SEAL ARRANGEMENT
ANTIFRICTION BEARING WITH SIGNAL GENERATOR AND METHOD FOR USING SAME
ANTIFRICTION BODY HAVING AN ANTIFRICTION LAYER
ANTIFRICTION DEVICE, PARTICULARLY FOR SKI BINDINGS
ANTIFRICTION ELEMENT FOR USE BETWEEN RELATIVELY SLIDING COMPONENTS OF AN ADJUSTABLE STEERING COLUMN
ANTIFRICTION FORCE TRANSMISSION MEANS FOR PLUNGERS OF TORQUE SIGNALLING WRENCHES
ANTIFRICTION MECHANICAL JOINT FOR AN ORTHOPEDIC KNEE BRACE
ANTIFRICTION MOUNTING HAVING A ROTATIONAL-SPEED MEASURING DEVICE PROTECTED FROM CONTAMINATION
ANTIFRICTION ROLLER BEARING
ANTIFRICTION ROLLER MEANS FOR PLUNGERS
ANTIFRICTION SCREW DRIVE |
|
Inventions Browse
Copyright © Philip M. Parker, INSEAD. Terms of Use.